NM_004004.6:c.283G>A
Variant summary
The NM_004004.6(GJB2):c.283G>A (p.Val95Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene GJB2 is a tumor suppressor gene (CancerMine: 5 TSG, 1 oncogene citations). The gene GJB2 is a known oncogene (CancerMine: 5 TSG, 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.0000483 (AC=78) in the gnomAD database across 1,613,992 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000215. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV002511670: One publication reports that the variant negatively impacted large molecule trafficking across gap junctions, thereby disrupting gap junction mediated intracellular signaling (Zhang_2005)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.V95A: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 496217) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.V95L: VUS-low (ClinVar VariationId 4856990, 1 star) The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.). This exact variant is curated in the UniProt human variants database as Pathogenic, associated with Deafness, autosomal recessive, 1A (DFNB1A); it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_004004.6 missense
Scores
Clinical Significance
Conservation
Publications
- Bart-Pumphrey syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- hearing loss disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- ichthyosis, hystrix-like, with hearing lossInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
- keratoderma hereditarium mutilansInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- palmoplantar keratoderma-deafness syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- autosomal recessive nonsyndromic hearing loss 1AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant keratitis-ichthyosis-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, PanelApp Australia
- autosomal dominant nonsyndromic hearing loss 3AInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- KID syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_pathogenic. The variant received 6 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★) | ||
| O5Same location/impact as known oncogenic | Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 11 pathogenic, 0 benign (OR vs. background: 115.0); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 0.44 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_004004.6. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
GJB2 | TSL:1MANE Select | c.283G>A p.Val95Met | missense | Exon 2 of 2 | Prot: ENSP00000372299.4 UniProt: | |
GJB2 | TSL:6 | c.283G>A p.Val95Met | missense | Exon 1 of 1 | Prot: ENSP00000372295.1 UniProt: | |
GJB2 | c.283G>A p.Val95Met | missense | Exon 2 of 2 | Prot: ENSP00000576289.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000788 | AC:12 | Hom:0 | AN:152194 | Cov:33 |
GnomAD2 exomes | AF: 0.0000478 | AC:12 | AN:251118 | ||
GnomAD4 exome | AF: 0.0000452 | AC:66 | Hom:0 | AN:1461678 | Cov:33 |
GnomAD4 genome | AF: 0.0000788 | AC:12 | Hom:0 | AN:152314 | Cov:33 |
TOPMed (Bravo) | AF: 0.0000416 | AC:11 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000564 | AC:20 | Hom:0 | AN:354820 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000104 * | 1 | 9622 | 0.00 * | 0 | 10428 |
Epi25 | 0.00 | 0 | 41958 | 0.0000449 | 3 | 66888 |
SCHEMA | 0.0000447 | 5 | 111944 | 0.0000380 | 7 | 184316 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 27 | |
AlphaMissense | Pathogenic | 0.78 | |
BayesDel_addAF | Pathogenic | 0.32 | D |
BayesDel_noAF | Pathogenic | 0.47 | |
CADD | Pathogenic | 26 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.90 | D |
Eigen | Pathogenic | 0.78 | |
Eigen_PC | Pathogenic | 0.72 | |
FATHMM_MKL | Uncertain | 0.92 | D |
GPN-Star LLR | N/A | -7.9 | |
GPN-Star score | N/A | 7.9 | |
LIST_S2 | Uncertain | 0.97 | D |
M_CAP | Pathogenic | 0.44 | D |
MetaRNN | Pathogenic | 0.96 | D |
MetaSVM | Pathogenic | 1.1 | D |
Mutation Taster | N/A | 3/97 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 3.1 | M |
PhyloP100 | Benign | 2.2 | |
popEVE | Benign | -3.2 | |
PrimateAI | Uncertain | 0.69 | T |
PromoterAI | N/A | 0.030 | Neutral |
PROVEAN | Uncertain | -2.9 | D |
REVEL | Pathogenic | 0.89 | |
Sift | Uncertain | 0.0010 | D |
Sift4G | Uncertain | 0.024 | D |
Varity_R | N/A | 0.66 | |
VESM-3B | Benign | -7.3 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.